Articles

Healthcare & life sciences M&A: risks and insurance market trends

Read article

Insights

There is always something exciting happening at Lockton. Here are just a few from our newsroom.

1 / 6
Articles

The FCA’s new Consumer Duty: additional focus on consumer outcomes

This article was first published on 23 February 2023. Last updated on 01 August 2023. The Financial Conduct Authority’s new Consumer Duty took effect in the UK on 31 July 2023. With it comes increased regulatory risk for financial institutions which  …

Read Article
Articles

How tech-fins can minimise their insurance premiums

There are many similarities between ‘fintechs’ and ‘techfins’, each of which use technology to deliver financial solutions. But for outsiders to the sector, it can often be difficult to tell them apart. When it comes to insurance, techfins have a rel …

Read Article
Whitepapers

The metaverse: Navigating the evolving risk landscape for retailers

From physical trading stalls and shopping centres to e-commerce and online shopping, the retail sector is constantly evolving to increase efficiency and outreach, whilst elevating customer experience. For the next wave of technological development, T …

Read Article
Articles

De-risking environmentally friendly construction

The real estate and construction sector is exploring options to make buildings more environmentally friendly. However, new concepts and designs can have a negative side-effect introducing fire or property risks that need to be addressed to improve bu …

Read Article
Articles

Quantifying ‘ESG’: the consequences for D&O insurance

The use of environmental, social, and governance (ESG) benchmarking to assess company performance in this area is increasingly popular among investors and insurers alike. But given a lack of regulation around each platforms’ assessment methodologies, …

Read Article
Articles

Intellectual property: rising infringement risk as life sciences booms

The life sciences sector is an increasingly prolific producer of intellectual property (IP). As it continues to attract investment in the UK and abroad, this trend is likely to continue. But for life sciences firms, and for their investors, the prote …

Read Article

Recent News

news-thumb-desktopnews-thumb-mobile
Read Article news